» Articles » PMID: 29713309

Nontoxic Goiter (NTG) and Radioiodine: What Do Patients Think About It? Quality of Life in Patients with NTG Before and After 131-I Therapy

Overview
Specialty Endocrinology
Date 2018 May 2
PMID 29713309
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Despite numerous publications regarding nontoxic goiter (NTG) treatment and an increasing interest in patients' quality of life, few studies present the outcome of 131-I treatment from the patients' perspective. Our study's main aim was to verify whether there is any improvement in life quality following 131-I treatment.

Materials And Methods: Thirty-five patients with NTG qualified to participate in the study. All patients completed a Thyroid-Related Health-Related Quality of Life (Thy-R-HRQoL) questionnaire created by us and the Medical Outcomes Study 36-item Short Form (SF-36), right before and 1 year after 131-I.

Results: We observed an improvement in six out of eight SF-36 and three out of seven Thy-R-HRQoL domains. In comparison with the control group, we observed worse results in two out of eight, prior to treatment, and one out of eight SF-36 afterward, as well as in all Thy-R-HRQoL domains. We did not find any correlation between improvement of Thy-R-HRQoL and SF-36 and goiter size reduction, except for Bodily Pain. There was also no correlation between improvement of SF-36 and Thy-R-HRQoL domains, and goiter size before treatment. The older the patient, the less noticeable improvement was observed in Physical and Social Functioning, and Vitality in SF-36, but age had no influence on the assessment by Thy-R-HRQoL.

Conclusion: Radioiodine treatment improves life quality in patients with NTG. Use of the Health-Related Quality of Life questionnaire should be taken into consideration when evaluating life quality of patients with NTG. Relentless pursuit of maximal goiter size reduction in 131-I treatment is worth consideration. In our study, life quality improvement did not depend directly on the goiter size reduction. Life quality improvement after 131-I might not depend on initial goiter size, and for certain domains of SF-36 might be less clearly expressed in older patients.

Citing Articles

Quality of Life Outcomes Following Radioactive lodine 131 Therapy in Hyperthyroid Patients: Insights from the Thyroid Patient-Reported Outcome Questionnaire.

Afsin H, Caliskan B Mol Imaging Radionucl Ther. 2025; 34(1):38-47.

PMID: 39918024 PMC: 11827516. DOI: 10.4274/mirt.galenos.2024.21548.


Thyroid disease-specific quality of life questionnaires - A systematic review.

Uslar V, Becker C, Weyhe D, Tabriz N Endocrinol Diabetes Metab. 2022; 5(5):e357.

PMID: 35856310 PMC: 9471597. DOI: 10.1002/edm2.357.


Quality of Life in Patients with Benign Non-Toxic Goiter After Surgical Intervention: A Systematic Review and Meta-Analysis.

Chaves N, Rodriguez M, Broekhuis J, Chen H, Bain P, James B World J Surg. 2022; 46(5):1093-1104.

PMID: 35075521 DOI: 10.1007/s00268-022-06452-w.

References
1.
Watt T, Groenvold M, Rasmussen A, Bonnema S, Hegedus L, Bjorner J . Quality of life in patients with benign thyroid disorders. A review. Eur J Endocrinol. 2006; 154(4):501-10. DOI: 10.1530/eje.1.02124. View

2.
Fast S, Nielsen V, Grupe P, Boel-Jorgensen H, Bastholt L, Andersen P . Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter. J Clin Endocrinol Metab. 2012; 97(8):2653-60. DOI: 10.1210/jc.2011-3335. View

3.
Kaniuka-Jakubowska S, Lewczuk A, Mizan-Gross K, Piskunowicz M, Zapasnik A, Lass P . Large multinodular goiter--outpatient radioiodine treatment. Endokrynol Pol. 2015; 66(4):301-7. DOI: 10.5603/EP.2015.0038. View

4.
Promberger R, Hermann M, Pallikunnel S, Seemann R, Meusel M, Ott J . Quality of life after thyroid surgery in women with benign euthyroid goiter: influencing factors including Hashimoto's thyroiditis. Am J Surg. 2013; 207(6):974-9. DOI: 10.1016/j.amjsurg.2013.05.005. View

5.
Mishra A, Sabaretnam M, Chand G, Agarwal G, Agarwal A, Verma A . Quality of life (QoL) in patients with benign thyroid goiters (pre- and post-thyroidectomy): a prospective study. World J Surg. 2013; 37(10):2322-9. DOI: 10.1007/s00268-013-2133-3. View